StonvexLoading…
StonvexStonvexStonvexCore line items from THO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $4.51B | $2.39B | $9.58B | $7.06B |
Operating Income | $53.48M | $32.49M | $296.19M | $152.82M |
Net Income | $39.47M | $21.67M | $258.56M | $132.80M |
EPS (Diluted) | $0.75 | $0.41 | $4.84 | $2.49 |
Total Assets | $7.02B | $6.99B | $7.07B | $7.17B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $242.18M | $509.88M | $586.60M | $508.32M |
Free Cash Flow OCF − CapEx | $-219.99M | $-74.78M | $456.31M | $234.73M |
Shares Outstanding | 52.91M | 52.98M | 53.40M | 53.44M |